Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases.

about

Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases.

Item

http://www.wikidata.org/entity/Q35786366

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Structure-Activity Relationshi ...... ceptor and Other Angiokinases.

@ast

Structure-Activity Relationshi ...... ceptor and Other Angiokinases.

@en

type

Item

label

Structure-Activity Relationshi ...... ceptor and Other Angiokinases.

@ast

Structure-Activity Relationshi ...... ceptor and Other Angiokinases.

@en

prefLabel

Structure-Activity Relationshi ...... ceptor and Other Angiokinases.

@ast

Structure-Activity Relationshi ...... ceptor and Other Angiokinases.

@en

P1476

Structure-Activity Relationshi ...... eceptor and Other Angiokinases

@en

P2093

Ara Kwon

http://www.w3.org/2001/XMLSchema#string

Bong-Yong Lee

http://www.w3.org/2001/XMLSchema#string

Doran Kim

http://www.w3.org/2001/XMLSchema#string

Hong Khanh Nguyen

http://www.w3.org/2001/XMLSchema#string

Jakyung Yoo

http://www.w3.org/2001/XMLSchema#string

Kyung Hoon Min

http://www.w3.org/2001/XMLSchema#string

Wonhee Suh

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor

Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein

Angiogenesis in cancer and other diseases

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Pazopanib, a new therapy for metastatic soft tissue sarcoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.

Sunitinib in patients with metastatic renal cell carcinoma.

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors.

P304

e0138823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0138823

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jiho Song

P577

2015-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282152275

http://www.w3.org/2001/XMLSchema#string

P698

26401847

http://www.w3.org/2001/XMLSchema#string

P932

4581874

http://www.w3.org/2001/XMLSchema#string